The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HIK HIKMA PHARMACEUTICALS PLC ORD SHS 10P




Fundamentals data is provided by FTSE Russell Data Solutions. To provide comparable issuer data, information has been standardised by FTSE Russell Data Solutions using globally adopted XBRL taxonomies. The data presented may therefore differ from an issuer's annual report and 'as reported' data should be obtained directly from the source issuer.

Data is provided "AS IS", with all faults, and on an "AS AVAILABLE" basis for information purposes only. London Stock Exchange is not liable for any errors, omissions or other defects in the data, or for any decisions taken in reliance of the data. Please see our full disclaimer here: https://www.londonstockexchange.com/global/legal/disclaimer.htm
Income Statement 31-Dec-14
( $ m )
31-Dec-15
( $ m )
31-Dec-16
( $ m )
31-Dec-17
( $ m )
31-Dec-18
( $ m )
Continuing Operations
Revenue  1489.00 1440.00 1950.00 1936.00 2070.00
Operating Profit/(Loss)  402.00 381.00 302.00 -747.00 371.00
Net Interest  -34.00 -53.00 -59.00 -57.00 -51.00
Profit Before Tax  368.00 318.00 210.00 -738.00 293.00
Profit After Tax  288.00 254.00 158.00 -839.00 285.00
Discontinued Operations
Profit After Tax  n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD  282.00 254.00 158.00 -839.00 285.00
Attributable to:
Minority Interests  -4.00 -2.00 -3.00 -4.00 -3.00
Equity Holders of Parent Company  278.00 252.00 155.00 -843.00 282.00
 
Continuing EPS
Earnings per Share - Basic  140.40¢ 126.60¢ 66.50¢ -351.30¢ 117.00¢
Earnings per Share - Diluted  139.00¢ 125.40¢ 66.20¢ -349.80¢ 116.50¢
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  140.40¢ 126.60¢ 66.50¢ -351.30¢ 117.00¢
Earnings per Share - Diluted  139.00¢ 125.40¢ 66.20¢ -349.80¢ 116.50¢
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  32.00¢ 32.00¢ 33.00¢ 34.00¢ 38.00¢

Balance Sheet 31-Dec-14
( $ m )
31-Dec-15
( $ m )
31-Dec-16
( $ m )
31-Dec-17
( $ m )
31-Dec-18
( $ m )
Assets
Non-Current Assets
Property, Plant & Equipment  514.00 507.00 969.00 828.00 870.00
Intangible Assets  602.00 607.00 1719.00 785.00 766.00
Investment Properties  n/a n/a n/a n/a n/a
Investments  16.00 7.00 7.00 6.00 11.00
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  39.00 46.00 48.00 60.00 57.00
  1238.00 1237.00 2915.00 1814.00 1829.00
Current Assets
Inventories  273.00 251.00 459.00 488.00 528.00
Trade & Other Receivables  397.00 449.00 715.00 666.00 674.00
Cash at Bank & in Hand  280.00 553.00 155.00 227.00 276.00
Current Asset Investments  n/a n/a n/a n/a n/a
Other Current Assets  11.00 65.00 73.00 99.00 59.00
  1013.00 1360.00 1448.00 1574.00 1668.00
 
Total Assets  2251.00 2597.00 4363.00 3388.00 3497.00
 
Liabilities
Current Liabilities
Borrowings  394.00 116.00 117.00 86.00 74.00
Other Current Liabilities  199.00 200.00 458.00 346.00 354.00
  841.00 592.00 918.00 797.00 893.00
 
Net Current Assets  172.00 768.00 530.00 777.00 775.00
 
Non-Current Liabilities
Borrowings  168.00 612.00 742.00 690.00 562.00
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  1.00 20.00 277.00 324.00 329.00
  194.00 653.00 1034.00 1063.00 907.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  1054.00 1260.00 1967.00 1874.00 1812.00
 
Net Assets  1197.00 1337.00 2396.00 1514.00 1685.00
 
Capital & Reserves
Share Capital  35.00 35.00 40.00 40.00 40.00
Share Premium Account  281.00 282.00 282.00 282.00 282.00
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  n/a n/a n/a n/a 1580.00
Shareholders Funds  1197.00 1337.00 2396.00 1514.00 1685.00
 
Minority Interests/Other Equity  19.00 15.00 15.00 14.00 12.00
Total Equity *   1216.00 1352.00 2411.00 1528.00 1697.00

Ratios - based on IFRS 31-Dec-14 31-Dec-15 31-Dec-16 31-Dec-17 31-Dec-18
Continuing Operations
PE Ratio *   21.99 26.90 35.01 n/a 18.77
PEG *   0.72 -2.74 -0.74 n/a n/a
Earnings per Share Growth  30.48% -9.83% -47.62% n/a n/a
Dividend Cover *   4.39 3.96 2.02 -10.33 3.08
Revenue Per Share  752.02¢ 723.62¢ 834.62¢ 806.67¢ 858.92¢
Pre-Tax Profit per Share  185.86¢ 159.80¢ 89.88¢ -307.50¢ 121.58¢
Operating Margin  27.00% 26.46% 15.49% -38.58% 17.92%
Return on Capital Employed  24.98% 19.93% 11.32% -26.94% 16.09%
 
Continuing & Discontinued Operations
Dividend Yield *   1.04% 0.94% 1.42% 2.28% 1.73%
Dividend per Share Growth  60.00% 0.00% 2.84% 3.31% 11.76%
Net Asset Value per Share (exc. Intangibles)  299.61¢ 366.13¢ 280.96¢ 302.94¢ 380.67¢
Net Gearing *   23.56% 13.09% 29.38% 36.26% 21.36%

Data provided by FTSE Russell



Company Information
Company website http://www.hikma.com
Company address 1 New Burlington Place, London, W1S 2HR, United Kingdom
FTSE ICB sector Pharmaceuticals & Biotechnology
FTSE ICB subsector Pharmaceuticals
Company market cap, £m* 4,092.46
Admission date 04 Nov 2005
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.

Security Information
FTSE index FTSE 100,FTSE 350,FTSE 350 Low Yield,FTSE 350 (ex IT),FTSE All-Share,FTSE All-Share (ex IT),FTSE Euromid
Market Main Market
Market identifier code (MIC) XLON
Trading service SETS
Trading segment SET1
Listing category Premium Equity Commercial Companies
Country of share register GB
ISIN GB00B0LCW083
SEDOL B0LCW08
Exchange market size 1,000
Security market cap, £m 4,092.46
*The market capitalisation of the security reflects data from previous trading day.


HIKMA share fundamentals (HIK)